Bosch Home Comfort India Ltd shareholders have overwhelmingly approved the appointments of Marcel Heese and Rishi Mehta as directors, and Rishi Mehta as ED-Finance & CFO. Sanjay Sudhakaran was re-appointed as MD. These approvals signal shareholder confidence in the company's leadership structure.
Bosch Home Comfort India Ltd Shareholders Back Leadership Appointments
99.96% of votes in favour for Mr. Marcel Heese (Director)
99.76% of votes in favour for Mr. Rishi Mehta (Director)
## What just happened Bosch Home Comfort India Ltd announced the outcome of its postal ballot, conducted from May 21 to June 19, 2026. Shareholders overwhelmingly approved four key resolutions related to management appointments. ## Why this matters The high assent percentages demonstrate strong shareholder confidence in the proposed leadership changes. These appointments formalize key roles, including a new Finance Director and CFO, and confirm the Managing Director's tenure, ensuring governance stability. ## The backstory Bosch Home Comfort India Ltd was formerly known as Johnson Controls-Hitachi Air Conditioning India Limited. The postal ballot sought approval for directorial appointments and the re-appointment of the Managing Director. ## What changes now Mr. Marcel Heese is now formally appointed as a Director from May 19, 2026. Mr. Rishi Mehta's appointments as Director and Executive Director-Finance & CFO (until September 30, 2028) are effective from April 1, 2026. Mr. Sanjay Sudhakaran will continue as Managing Director for another three-year term starting July 1, 2026. ## Risks to watch No specific risks were mentioned in the filing. The high approval margins suggest minimal immediate governance concerns from shareholders. ## Peer comparison Information on peer company management changes is not available in this filing. ## Context metrics (time-bound) * Total equity shares voted: 2,07,37,565. * Mr. Marcel Heese: Appointed Director (effective May 19, 2026). * Mr. Rishi Mehta: Appointed Director (effective April 1, 2026), Appointed ED-Finance & CFO (April 1, 2026 - September 30, 2028). * Mr. Sanjay Sudhakaran: Re-appointed MD (July 1, 2026 - June 30, 2029). ## What to track next Investors should monitor the company's operational performance under the newly formalized leadership team and any future strategic announcements. Reader Takeaway: Shareholder approval ensures management stability with new finance leadership and confirmed MD.